{"schema_version":"secwatch.filing_event.v1","accession":"0001646972-25-000080","form_type":"8-K","ticker":"ACI","cik":"0001646972","company_name":"Albertsons Companies, Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.037251+00:00","generated_at":"2026-05-17T03:54:32.994229+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"confidence":"high","headline":"Albertsons Q2 adj. EPS $0.44 vs $0.51 YoY; announces $750M ASR, raises FY25 EPS outlook","bullets":["Net income $168.5M ($0.30/sh) vs $145.5M ($0.25) YoY; adjusted net income $248.4M ($0.44/sh) down from $301M ($0.51).","Identical sales up 2.2% (adj); digital sales +23%; loyalty members +13% to 48.7M.","Gross margin rate decreased to 27.0% from 27.6%, pressured by pharmacy growth and digital costs.","Entered $750M accelerated share repurchase with JPMorgan; Board increased repurchase program to $2.75B.","FY2025 outlook raised: identical sales 2.2%-2.75%, adj. EPS $2.06-$2.19, capex $1.8B-$1.9B."],"urls":{"canonical":"https://secwatch.observer/filing/0001646972-25-000080","json":"https://secwatch.observer/filing/0001646972-25-000080.json","markdown":"https://secwatch.observer/filing/0001646972-25-000080.md","text":"https://secwatch.observer/filing/0001646972-25-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1646972/000164697225000080/0001646972-25-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1646972/000164697225000080/aci-20251014.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:54:32.994229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}